Vivani Medical Announces $8.25M Private Placement Equity Financing
Provided By GlobeNewswire
Last update: Mar 27, 2025
Financing strengthens balance sheet, extending expected runway into the second quarter of 2026
Enables accelerated development of NPM-139, Company’s once or twice-yearly GLP-1 (semaglutide) implant under development for chronic weight management
Read more at globenewswire.comNASDAQ:VANI (9/12/2025, 8:23:15 PM)
1.21
+0.01 (+0.83%)
Find more stocks in the Stock Screener
